HYPOPHARYNX CANCER
Clinical trials for HYPOPHARYNX CANCER explained in plain language.
Never miss a new study
Get alerted when new HYPOPHARYNX CANCER trials appear
Sign up with your email to follow new studies for HYPOPHARYNX CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to shrink radiation damage and fight cancer
Disease control Recruiting nowThis study is for people with certain head and neck cancers (oropharynx, larynx, hypopharynx) that haven't spread past the midline. It tests two ideas: using a smaller radiation target to reduce side effects, and adding the drug ATRA to help prevent the cancer from coming back. A…
Matched conditions: HYPOPHARYNX CANCER
Phase: PHASE3 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated May 26, 2026 03:36 UTC
-
Pill combo could offer new hope for rural head and neck cancer patients
Disease control Recruiting nowThis study is testing whether taking three oral drugs (methotrexate, erlotinib, and celecoxib) together is safe and practical for people with head and neck cancer that has come back or spread. The trial focuses on patients in rural Midwest areas, aiming to make treatment more acc…
Matched conditions: HYPOPHARYNX CANCER
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 03:31 UTC
-
New drug cocktail aims to shrink Hard-to-Treat head and neck tumors
Disease control Recruiting nowThis study tests whether combining two drugs, sacituzumab govitecan and cetuximab, can shrink tumors in people with advanced head and neck cancer that has gotten worse after first-line therapy. About 40 adults with certain types of head and neck cancer will receive the drug combi…
Matched conditions: HYPOPHARYNX CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:55 UTC